TY - JOUR
T1 - In vitro propagation and secondary metabolite production in Gloriosa superba L
AU - Sanyal, Rupa
AU - Nandi, Saheli
AU - Pandey, Sharmila
AU - Das, Tuyelee
AU - Kaur, Prabhjot
AU - Konjengbam, Merinashwari
AU - Kant, Nishi
AU - Rahman, Md Habibur
AU - Mundhra, Avinash
AU - Kher, Mafatlal M.
AU - Anand, Uttpal
AU - Radha,
AU - Kumar, Manoj
AU - Jha, Niraj Kumar
AU - Jha, Saurabh Kumar
AU - Shekhawat, Mahipal S.
AU - Pandey, Devendra Kumar
AU - Dey, Abhijit
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Abstract: Gloriosa superba L., commonly known as “gloriosa lily,” “glory lily,” and “tiger claw,” is a perennial climber in the Liliaceae family. This plant is used in African and Southeast Asian cultures as an ayurvedic medicinal herb to treat various health conditions. Its main bioactive component is colchicine, which is responsible for medicinal efficacies as well as poisonous properties of the plant. A high market demand, imprudent harvesting of G. superba from natural habitat, and low seed setting have led scientists to explore micropropagation techniques and in vitro optimization of its phytochemicals. Plant growth regulators have been used to induce callus, root, and shoot organogenesis, and somatic embryogenesis in vitro. This review is aimed at presenting information regarding the occurrence, taxonomic description, phytochemistry, micropropagation, in vitro secondary metabolite, and synthetic seed production. The data collected from the existing literature, along with an analysis of individual study details, outcomes, and variations in the reports, will contribute to the development of biotechnological strategies for conservation and mass propagation of G. superba. Key points: • Latest literature on micropropagation of Gloriosa superba. • Biotechnological production and optimization of colchicine. • Regeneration, somatic embryogenesis, and synthetic seed production.
AB - Abstract: Gloriosa superba L., commonly known as “gloriosa lily,” “glory lily,” and “tiger claw,” is a perennial climber in the Liliaceae family. This plant is used in African and Southeast Asian cultures as an ayurvedic medicinal herb to treat various health conditions. Its main bioactive component is colchicine, which is responsible for medicinal efficacies as well as poisonous properties of the plant. A high market demand, imprudent harvesting of G. superba from natural habitat, and low seed setting have led scientists to explore micropropagation techniques and in vitro optimization of its phytochemicals. Plant growth regulators have been used to induce callus, root, and shoot organogenesis, and somatic embryogenesis in vitro. This review is aimed at presenting information regarding the occurrence, taxonomic description, phytochemistry, micropropagation, in vitro secondary metabolite, and synthetic seed production. The data collected from the existing literature, along with an analysis of individual study details, outcomes, and variations in the reports, will contribute to the development of biotechnological strategies for conservation and mass propagation of G. superba. Key points: • Latest literature on micropropagation of Gloriosa superba. • Biotechnological production and optimization of colchicine. • Regeneration, somatic embryogenesis, and synthetic seed production.
KW - Colchicine
KW - Gloriosa superba
KW - Micropropagation
KW - Plant growth regulators
KW - Somatic embryogenesis
KW - Synthetic seed
UR - http://www.scopus.com/inward/record.url?scp=85135755724&partnerID=8YFLogxK
U2 - 10.1007/s00253-022-12094-8
DO - 10.1007/s00253-022-12094-8
M3 - Review article
C2 - 35941253
AN - SCOPUS:85135755724
SN - 0175-7598
VL - 106
SP - 5399
EP - 5414
JO - Applied Microbiology and Biotechnology
JF - Applied Microbiology and Biotechnology
IS - 17
ER -